(Q39998314)

English

The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

0 references

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mei-Ren Pan

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hui-Chiu Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lea-Yea Chuang

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Wen-Chun Hung

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Experimental Biology and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

233

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

456-462

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents.

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

COX-2: a molecular target for colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Cyclins and cyclin-dependent kinases: take your partners

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Mechanisms underlying nonsteroidal anti-inflammatory drug-induced p27(Kip1) expression

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Biochemistry and biology of mammalian DNA methyltransferases

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Aberrant methylation of SPARC in human lung cancers

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.3181%2F0709-RM-257

21 January 2018

Identifiers

10.3181/0709-RM-257

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39998314&oldid=1966797977"